Product: Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA  NDC 76318-334-50
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20210217
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated